Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 296

    1.

    Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.

    Al-Khatib SM, Anstrom KJ, Eisenstein EL, Peterson ED, Jollis JG, Mark DB, Li Y, O'Connor CM, Shaw LK, Califf RM.

    Ann Intern Med. 2005 Apr 19;142(8):593-600.PMID: 15838065 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.

    Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.

    J Am Coll Cardiol. 2006 Jul 4;48(1):112-21. Epub 2006 Jun 9.PMID: 16814657 [PubMed - indexed for MEDLINE]Related articles

    3.

    A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

    Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

    Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.PMID: 16904046 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

    Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ.

    J Am Coll Cardiol. 2006 Jun 6;47(11):2310-8. Epub 2006 May 4.PMID: 16750701 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cost-effectiveness of implantable cardioverter-defibrillators.

    Sanders GD, Hlatky MA, Owens DK.

    N Engl J Med. 2005 Oct 6;353(14):1471-80.PMID: 16207849 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death.

    Spath MA, O'Brien BJ.

    Pharmacoeconomics. 2002;20(11):727-38. Review.PMID: 12201792 [PubMed - indexed for MEDLINE]Related articles

    7.

    Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.

    Sanders GD, Hlatky MA, Every NR, McDonald KM, Heidenreich PA, Parsons LS, Owens DK.

    Ann Intern Med. 2001 Nov 20;135(10):870-83.PMID: 11712877 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence.

    Lynd LD, O'Brien BJ.

    J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S99-103. Review.PMID: 12950529 [PubMed - indexed for MEDLINE]Related articles

    10.

    Summaries for patients. What are the clinical and economic implications of following MADIT-II criteria for surgically implanting automatic cardiac defibrillators?

    [No authors listed]

    Ann Intern Med. 2005 Apr 19;142(8):I39. No abstract available. PMID: 15838059 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial.

    Sharma PP, Greenlee RT, Anderson KP, Chyou PH, Osorio HJ, Smith PN, Hayes JH, Vidaillet H.

    J Interv Card Electrophysiol. 2007 Sep;19(3):157-64. Epub 2007 Sep 6.PMID: 17805953 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure.

    Chen L, Hay JW.

    Cardiovasc Drugs Ther. 2004 Mar;18(2):161-70.PMID: 15162078 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

    Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH; SCD-HeFT Investigators.

    Circulation. 2006 Jul 11;114(2):135-42. Epub 2006 Jul 3.PMID: 16818817 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review.

    Bryant J, Brodin H, Loveman E, Payne E, Clegg A.

    Health Technol Assess. 2005 Sep;9(36):1-150, iii. Review.PMID: 16153353 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS).

    O'Brien BJ, Connolly SJ, Goeree R, Blackhouse G, Willan A, Yee R, Roberts RS, Gent M.

    Circulation. 2001 Mar 13;103(10):1416-21.PMID: 11245646 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.

    Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG.

    Eur Heart J. 2007 Jan;28(1):42-51. Epub 2006 Nov 16.PMID: 17110403 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

    Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

    Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.PMID: 17999842 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis.

    O'Brien BJ, Buxton MJ, Rushby JA.

    Br Heart J. 1992 Aug;68(2):241-5.PMID: 1389748 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.

    Cowie MR, Marshall D, Drummond M, Ferko N, Maschio M, Ekman M, de Roy L, Heidbuchel H, Verboven Y, Braunschweig F, Linde C, Boriani G.

    Europace. 2009 Jun;11(6):716-26. Epub 2009 Apr 9.PMID: 19359333 [PubMed - indexed for MEDLINE]Related articles